Tibet Weixinkang Medicine Co., Ltd.
SSE:603676.SS
11.51 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 216.438 | 269.426 | 519.322 | 243.774 | 219.52 | 159.682 | 154.275 | 75.37 | 89.274 | 136.312 | 77.559 | 99.793 |
| Short Term Investments
| 803 | 625.322 | 287 | 467.775 | 356 | 369.9 | -5.046 | 386.707 | 78.5 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 1,019.438 | 894.748 | 806.322 | 711.549 | 575.52 | 529.582 | 154.275 | 75.37 | 89.274 | 136.312 | 77.559 | 99.793 |
| Net Receivables
| 174.224 | 181.964 | 222.852 | 193.133 | 229.074 | 272.973 | 259.495 | 152.997 | 27.933 | 0 | 13.877 | 29.219 |
| Inventory
| 41.957 | 38.344 | 32.541 | 22.677 | 21.682 | 14.044 | 9.935 | 39.063 | 51.519 | 35.203 | 27.011 | 19.863 |
| Other Current Assets
| 79.752 | 87.046 | 77.257 | 81.799 | 68.661 | 84.748 | 422.571 | 562.799 | 12.922 | 66.256 | 27.459 | 12.419 |
| Total Current Assets
| 1,315.372 | 1,199.905 | 1,138.972 | 1,009.158 | 894.955 | 901.347 | 846.277 | 677.232 | 260.147 | 237.771 | 145.906 | 161.294 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 380.248 | 361.214 | 333.734 | 324.143 | 314.186 | 310.345 | 291.301 | 222.728 | 229.668 | 195.062 | 158.285 | 105.53 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0.215 | 0.215 | 0.215 | 0.215 | 0.215 | 0.215 |
| Intangible Assets
| 30.431 | 57.911 | 62.454 | 81.547 | 65.037 | 48.046 | 44.158 | 42.204 | 31.906 | 26.629 | 13.336 | 8.355 |
| Goodwill and Intangible Assets
| 30.431 | 57.911 | 62.454 | 81.547 | 65.037 | 48.046 | 44.373 | 42.42 | 32.122 | 26.844 | 13.551 | 8.57 |
| Long Term Investments
| -733.946 | 75.881 | -215.666 | -405.288 | -297.233 | -353.4 | 14.046 | 2.873 | 1.515 | 0.721 | 0.417 | 0.849 |
| Tax Assets
| 42.919 | 56.209 | 29.471 | 9.749 | 12.459 | 14.585 | 16.089 | 14.898 | 17.203 | 15.478 | 10.412 | 6.484 |
| Other Non-Current Assets
| 818.664 | 25.773 | 315.753 | 476.259 | 370.659 | 383.689 | 22.887 | 56.478 | 11.701 | 32.875 | 34.8 | 26.575 |
| Total Non-Current Assets
| 538.314 | 576.988 | 525.746 | 486.411 | 465.107 | 403.265 | 388.697 | 339.397 | 292.209 | 270.98 | 217.466 | 148.008 |
| Total Assets
| 1,853.686 | 1,776.893 | 1,664.718 | 1,495.569 | 1,360.062 | 1,304.612 | 1,234.973 | 1,016.628 | 552.356 | 508.751 | 363.372 | 309.302 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 269.62 | 229.158 | 236.871 | 244.632 | 267.634 | 269.625 | 215.988 | 77.684 | 6.32 | 7.212 | 5.132 | 4.926 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 26.605 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 9.144 | 10.802 | 20.475 | 12.81 | 15.022 | 11.493 | 13.483 | 7.433 | 9.68 | 18.388 | 18.733 | 17.569 |
| Deferred Revenue
| 0 | 0 | 6.538 | 171.214 | 8.977 | 11.922 | 13.483 | 18.654 | 20.35 | 23.782 | 0 | 0 |
| Other Current Liabilities
| 148.414 | 154.83 | 154.452 | 154.07 | 86.196 | 87.288 | 76.794 | 66.474 | 69.432 | 56.442 | 53.225 | 39.023 |
| Total Current Liabilities
| 427.178 | 394.789 | 411.797 | 419.258 | 368.852 | 368.406 | 332.87 | 151.591 | 85.432 | 105.824 | 77.091 | 61.518 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 2.383 | 3.819 | 3.48 | 2.348 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 7.049 | 0 | 5.254 | 6.699 | 8.001 | 6.154 | 4.464 | 6.871 | 7.503 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 2.778 | 3.46 | 0.462 | -6.699 | 0 | 0 | 0 | 0.122 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 28.855 | 34.479 | 23.14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 41.065 | 41.758 | 32.335 | 9.047 | 8.001 | 6.154 | 4.464 | 6.994 | 7.503 | 0 | 0 | 0 |
| Total Liabilities
| 468.244 | 436.548 | 444.133 | 428.305 | 376.853 | 374.56 | 337.334 | 158.585 | 92.935 | 105.824 | 77.091 | 61.518 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 142.352 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 435.162 | 435.162 | 435.162 | 435.919 | 423 | 423 | 423 | 423 | 360 | 360 | 2.1 | 2.1 |
| Retained Earnings
| 536.953 | 501.655 | 392.897 | 307.234 | 258.203 | 218.813 | 186.642 | 149.027 | 48.108 | -5.282 | 242.413 | 199.763 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0.779 | 109.756 | 38.926 | 56.78 | 43.013 | 42.771 | 40.791 | 51.313 | 48.186 | -0 | 0 |
| Other Total Stockholders Equity
| 413.327 | 260.397 | 392.528 | 324.111 | 302.006 | 288.239 | 287.997 | 245.226 | 51.313 | 48.186 | 41.678 | 33.901 |
| Total Shareholders Equity
| 1,385.442 | 1,340.346 | 1,220.585 | 1,067.264 | 983.209 | 930.052 | 897.639 | 858.044 | 459.421 | 402.904 | 286.192 | 235.763 |
| Total Equity
| 1,385.442 | 1,340.346 | 1,220.585 | 1,067.264 | 983.209 | 930.052 | 897.639 | 858.044 | 459.421 | 402.927 | 286.281 | 247.784 |
| Total Liabilities & Shareholders Equity
| 1,853.686 | 1,776.893 | 1,664.718 | 1,495.569 | 1,360.062 | 1,304.612 | 1,234.973 | 1,016.628 | 552.356 | 508.751 | 363.372 | 309.302 |